Global Lactose Intolerance Treatment Market, By Type (Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance and Developmental Lactose Intolerance), Treatment (Food Supplements, Enzymatic Lactase Supplements and Others), Route of Administration (Oral and Injectable), End Users (Hospitals, Homecare, Specialty Clinics and Others) – Industry Trends and Forecast to 2030.
Lactose Intolerance Treatment Market Analysis and Size
According to experts, approximately 68 percent of the world's population suffers from lactose malabsorption. The widespread prevalence of lactose intolerance is primarily driving the market. Lactose intolerance is uncommon in babies and young children and usually appears in adulthood. As a result, increasing age and ethnicity drive market growth. Small intestine problems such as bacterial overgrowth, celiac disease, and Crohn's disease can cause lactose intolerance, and intestinal complications from specific cancer treatments contribute to market growth. Huge financial support for researchers developing novel interventions is boosting market growth.
Data Bridge Market Research analyses that the lactose intolerance treatment market which is USD 29686.99 million in 2022, is expected to reach USD 50212.39 million by 2030, at a CAGR of 6.79% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Lactose Intolerance Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Primary Lactose Intolerance, Secondary Lactose Intolerance, Congenital Lactose Intolerance and Developmental Lactose Intolerance), Treatment (Food Supplements, Enzymatic Lactase Supplements and Others), Route of Administration (Oral and Injectable), End Users (Hospitals, Homecare, Specialty Clinics and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Johnson & Johnson Services, Inc (U.S.), Abbott (U.S.), Astrazeneca (U.K.), Amgen Inc. (U.S.), Novo Nordisk A/S (Denmark), Macleods Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Lupin Pharmaceuticals, Inc. (U.S.), Walter Bushnell (India), Nature's Way Brands (U.S.), Ritter Pharmaceuticals (U.S.), profarma (U.S.), Recordati S.p.A (Italy), Deerland Probiotics & Enzymes, Inc (U.S.), Novozymes (Denmark)
|
|
Market Opportunities
|
|
Market Definition
Lactose intolerance is a condition in which the patient has difficulty breaking down lactose, which is a natural sugar found in all dairy products. It is a gastrointestinal disorder in which not enough lactases are produced, which are responsible for breaking down this natural sugar. Additionally, the condition can cause abdominal pain, flatulence, bloating, cramps, acidity, and diarrhoea.
Lactose Intolerance Treatment Market Dynamics
Drivers
- Prevalence of Lactose deficiency worldwide
Lactose malabsorption affects approximately 68 percent of the world's population, according to experts. The widespread prevalence of lactose intolerance primarily drives the market. Lactose intolerance is uncommon in infants and young children and usually manifests itself in adulthood. As a result, increasing age and ethnicity boost market growth. Small intestine issues such as bacterial overgrowth, celiac disease, and Crohn's disease can cause lactose intolerance, and intestinal complications from certain cancer treatments also contribute to market growth. Massive financial support for researchers developing novel interventions is boosting market growth.
Opportunities
- Rising healthcare infrastructure development spending
Growing age and ethnicity are major factors driving market growth. Rising healthcare infrastructure development spending and the prevalence of a family history of lactose intolerance are two other factors driving market growth. Other indirect determinants that will create lucrative market growth opportunities include growing small intestine diseases or disorders such as bacterial overgrowth, celiac disease, and Crohn's disease, as well as personal disposable income. These are the certain factors which propel the market growth.
Restraints/Challenges
- High cost
Non-favourable reimbursement scenarios in developing and developing economies will pose a significant challenge to market growth. Many companies' patents will expire, posing another challenge to the market's growth rate. A lack of information and medical expertise will further hamper market growth in the developing world. The high cost of treatment will also impede the growth of this market.
This lactose intolerance treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lactose intolerance treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Lactose Intolerance Treatment Market Scope
The lactose intolerance treatment market is segmented based on type, treatment, route of administration and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Primary Lactose Intolerance
- Secondary Lactose Intolerance
- Congenital Lactose Intolerance
- Developmental Lactose Intolerance
Treatment
- Food Supplements
- Enzymatic Lactase Supplements
- Others
Route of Administration
- Oral
- Injectable
End Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Lactose Intolerance Treatment Market Regional Analysis/Insights
The lactose intolerance treatment market is analyzed and market size insights and trends are provided by country, type, treatment, route of administration and end users as referenced above.
The countries covered in the lactose intolerance treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the lactose intolerance treatment market owing to the increasing prevalence of lactose intolerance, growing vegan lifestyle adoption, and favorable reimbursement scenario in this region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to rising expenditure to develop healthcare infrastructure and increasing incidences of small intestine diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The lactose intolerance treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for lactose intolerance treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lactose intolerance treatment market. The data is available for historic period 2011-2021.
Competitive Landscape and Lactose Intolerance Treatment Market Share Analysis
The lactose intolerance treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lactose intolerance treatment market.
Some of the major players operating in the lactose intolerance treatment market are:
- Johnson & Johnson Services, Inc (U.S.)
- Abbott (U.S.)
- Astrazeneca (U.K.)
- Amgen Inc. (U.S.)
- Novo Nordisk A/S (Denmark)
- Macleods Pharmaceuticals Ltd. (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Lupin Pharmaceuticals, Inc. (U.S.)
- Walter Bushnell (India)
- Nature's Way Brands (U.S.)
- Ritter Pharmaceuticals (U.S.)
- profarma (U.S.)
- Recordati S.p.A (Italy)
- Deerland Probiotics & Enzymes, Inc (U.S.)
- Novozymes (Denmark)
SKU-